Advertisement

A Clinical Investigation of Pivmecillinam, a Novel ß-Lactam Antibiotic, in the Treatment of Urinary Tract Infections

  • R. Wise
  • D. S. Reeves
  • J. M. Symonds
  • P. J. Wilkinson
Part of the Chemotherapy book series (CT, volume 5)

Summary

Pivmecillinam (FL1039) is the pivaloyloxymethyl ester of mecillinam (FL1060) which has considerable in vitro activity against Enterobacteriacae.

Thirty eight hospital inpatients who had proven urinary tract infections were treated with 400 mgs of pivmecillinam 4 times daily for 5–7 days. The MIC of mecillinam to the infecting organisms was determined as were the serum and urinary concentrations of the antibiotic.

The patients were followed up for 4–6 weeks after the end of treatment. Three patients were lost to follow up. Of the 35 patients who were adequately followed up, 29 (83%) were classified as cured and there were 6 failures. Reported side effects were of a minor nature.

Keywords

Urinary Tract Infection Minimum Inhibitory Concentration Hospital Inpatient Proteus Mirabilis Prostatic Hypertrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Christoffersen, J.C., Iversen, H.G., Jacobsen, J., Korner, B., Petersen, H.K., Rasmussen, F. and Tybring, L. FL1039 in bacteriuria following prostatectomy. Scandinavian Journal of Urology and Nephrology. (In Press).Google Scholar
  2. Davies, J.A., Strangeways, J.E.M., Mitchell, R.G., Beilia, L.J., Ledingham, J.G.C., and Holt, J.M. Comparative double blind trial of cephalexin and ampicillin in treatment of urinary tract infections. British Medical Journal 3: 215–217 (1971).PubMedCrossRefGoogle Scholar
  3. Greenwood, D., Brooks, L.H., Gargan, R., and O’Grady, F. Activity of FL1060 a new ß-lactam antibiotic, against urinary tract pathogens. Journal of Clinical Pathology 27: 192–197, (1974).PubMedCrossRefGoogle Scholar
  4. Lund, F., and Tybring, H., 6 ß-amidinopenicillanic acids a new group of antibiotics. Nature, New Biology 236: 135–137, (1972).Google Scholar
  5. Reeves, D.S., Faiers, M.C., Pursell, R.E., and Brumfitt, W. Trimethoprim-Sulphamethoxazole: Comparative study in urinary tract infections in hospital. British Medical Journal l: 541–544, (1969).Google Scholar
  6. Reeves, D.S., Wise, R., and Bywater, M.J. A laboratory evaluation of a novel ß-lactam antibiotic mecillinam; a treatment for bacterial infection. (To be published).Google Scholar
  7. Roholt, K., Nielsen, B., and Kristensen, E. Pharmacokinetic studies with mecillinam and pivmecillinam. (In Press).Google Scholar
  8. Verrier-Jones, E.R., and Asscher, A.W., Treatment of recurrent bacteriuria with pivmecillinam (FL1039). The Journal of Antimicrobial Chemotherapy. 1: 193–196, (1975).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • R. Wise
    • 1
  • D. S. Reeves
    • 1
  • J. M. Symonds
    • 1
  • P. J. Wilkinson
    • 1
  1. 1.Department of Medical MicrobiologySouthmead HospitalBristolUK

Personalised recommendations